S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: Phase II trial

Yong W. Moon, Soohyeon Lee, Byeong Woo Park, Eun Kyung Kim, Seung I. Kim, Ja S. Koo, Seho Park, Min J. Kim, Hyun C. Chung, Joo Hang Kim, Joohyuk Sohn

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint Dive into the research topics of 'S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: Phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences